As of 2025-05-16, the Relative Valuation of Edwards Lifesciences Corp (EW) is 209.44 USD. This relative valuation is based on P/E multiples. With the latest stock price at 78.00 USD, the upside of Edwards Lifesciences Corp based on Relative Valuation is 168.5%.
The range of the Relative Valuation is 79.96 - 381.02 USD.
| Range | Selected | |
| Trailing P/E multiples | 34.5x - 53.6x | 45.8x |
| Forward P/E multiples | 35.4x - 47.6x | 41.3x |
| Fair Price | 79.96 - 381.02 | 209.44 |
| Upside | 2.5% - 388.5% | 168.5% |
| Date | P/E |
| 2025-05-15 | 10.81 |
| 2025-05-14 | 10.79 |
| 2025-05-13 | 10.62 |
| 2025-05-12 | 10.52 |
| 2025-05-09 | 10.36 |
| 2025-05-08 | 10.49 |
| 2025-05-07 | 10.55 |
| 2025-05-06 | 10.54 |
| 2025-05-05 | 10.56 |
| 2025-05-02 | 10.64 |
| 2025-05-01 | 10.57 |
| 2025-04-30 | 10.62 |
| 2025-04-29 | 10.73 |
| 2025-04-28 | 10.62 |
| 2025-04-25 | 10.69 |
| 2025-04-24 | 10.56 |
| 2025-04-23 | 9.91 |
| 2025-04-22 | 9.93 |
| 2025-04-21 | 9.73 |
| 2025-04-17 | 10.06 |
| 2025-04-16 | 10.01 |
| 2025-04-15 | 9.95 |
| 2025-04-14 | 9.83 |
| 2025-04-11 | 9.76 |
| 2025-04-10 | 9.60 |
| 2025-04-09 | 9.83 |
| 2025-04-08 | 9.43 |
| 2025-04-07 | 9.70 |
| 2025-04-04 | 9.75 |
| 2025-04-03 | 10.26 |
| 2025-04-02 | 10.13 |
| 2025-04-01 | 10.11 |
| 2025-03-31 | 10.19 |
| 2025-03-28 | 9.97 |
| 2025-03-27 | 10.01 |
| 2025-03-26 | 10.00 |
| 2025-03-25 | 10.02 |
| 2025-03-24 | 10.03 |
| 2025-03-21 | 9.91 |
| 2025-03-20 | 9.98 |
| 2025-03-19 | 9.97 |
| 2025-03-18 | 9.89 |
| 2025-03-17 | 9.93 |
| 2025-03-14 | 9.74 |
| 2025-03-13 | 9.56 |
| 2025-03-12 | 9.63 |
| 2025-03-11 | 9.62 |
| 2025-03-10 | 9.64 |
| 2025-03-07 | 9.89 |
| 2025-03-06 | 10.10 |